127 related articles for article (PubMed ID: 25956029)
21. Nucleophosmin interacts with HEXIM1 and regulates RNA polymerase II transcription.
Gurumurthy M; Tan CH; Ng R; Zeiger L; Lau J; Lee J; Dey A; Philp R; Li Q; Lim TM; Price DH; Lane DP; Chao SH
J Mol Biol; 2008 Apr; 378(2):302-17. PubMed ID: 18371977
[TBL] [Abstract][Full Text] [Related]
22. Regulatory role of nucleophosmin during the differentiation of human liver cancer cells.
Xu DH; Liu F; Li X; Chen XF; Jing GJ; Wu FY; Shi SL; Li QF
Int J Oncol; 2014 Jul; 45(1):264-72. PubMed ID: 24787960
[TBL] [Abstract][Full Text] [Related]
23. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
Cosgrave N; Hill AD; Young LS
J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation and aberrant cytoplasmic expression of GLTSCR2 in prostatic adenocarcinomas.
Kim JY; Cho YE; Kim GY; Lee HL; Lee S; Park JH
Cancer Lett; 2013 Oct; 340(1):134-40. PubMed ID: 23920125
[TBL] [Abstract][Full Text] [Related]
25. c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance.
Pyndiah S; Tanida S; Ahmed KM; Cassimere EK; Choe C; Sakamuro D
Sci Signal; 2011 Mar; 4(166):ra19. PubMed ID: 21447800
[TBL] [Abstract][Full Text] [Related]
26. PPM1D controls nucleolar formation by up-regulating phosphorylation of nucleophosmin.
Kozakai Y; Kamada R; Furuta J; Kiyota Y; Chuman Y; Sakaguchi K
Sci Rep; 2016 Sep; 6():33272. PubMed ID: 27619510
[TBL] [Abstract][Full Text] [Related]
27. DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.
Gjerset RA
J Mol Histol; 2006 Sep; 37(5-7):239-51. PubMed ID: 16855788
[TBL] [Abstract][Full Text] [Related]
28. The expression of GLTSCR2, a candidate tumor suppressor, is reduced in seborrheic keratosis compared to normal skin.
Kim JY; Kim HS; Lee S; Park JH
Pathol Res Pract; 2010 May; 206(5):295-9. PubMed ID: 20185249
[TBL] [Abstract][Full Text] [Related]
29. PML4 induces differentiation by Myc destabilization.
Buschbeck M; Uribesalgo I; Ledl A; Gutierrez A; Minucci S; Muller S; Di Croce L
Oncogene; 2007 May; 26(23):3415-22. PubMed ID: 17146439
[TBL] [Abstract][Full Text] [Related]
30. Suppression of GLTSCR2 expression in renal cell carcinomas.
Cho YE; Lee HL; Lim SJ; Kim YW; Choe BK; Lee S; Park JH
Pathol Res Pract; 2016 Feb; 212(2):120-4. PubMed ID: 26724143
[TBL] [Abstract][Full Text] [Related]
31. p14ARF interacts with N-Myc and inhibits its transcriptional activity.
Amente S; Gargano B; Diolaiti D; Della Valle G; Lania L; Majello B
FEBS Lett; 2007 Mar; 581(5):821-5. PubMed ID: 17289033
[TBL] [Abstract][Full Text] [Related]
32. Role of GLTSCR2 in the regulation of telomerase activity and chromosome stability.
Kim JY; An YM; Park JH
Mol Med Rep; 2016 Aug; 14(2):1697-703. PubMed ID: 27357325
[TBL] [Abstract][Full Text] [Related]
33. The HBx oncoprotein of hepatitis B virus engages nucleophosmin to promote rDNA transcription and cellular proliferation.
Ahuja R; Kapoor NR; Kumar V
Biochim Biophys Acta; 2015 Aug; 1853(8):1783-95. PubMed ID: 25918010
[TBL] [Abstract][Full Text] [Related]
34. Ubiquitin-Dependent Turnover of MYC Antagonizes MYC/PAF1C Complex Accumulation to Drive Transcriptional Elongation.
Jaenicke LA; von Eyss B; Carstensen A; Wolf E; Xu W; Greifenberg AK; Geyer M; Eilers M; Popov N
Mol Cell; 2016 Jan; 61(1):54-67. PubMed ID: 26687678
[TBL] [Abstract][Full Text] [Related]
35. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
36. AML-associated mutation of nucleophosmin compromises its interaction with nucleolin.
Šašinková M; Holoubek A; Otevřelová P; Kuželová K; Brodská B
Int J Biochem Cell Biol; 2018 Oct; 103():65-73. PubMed ID: 30130654
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of GLTSCR2 expression is correlated with breast cancer progression.
Moon A; Lim SJ; Jo YH; Lee S; Kim JY; Lee J; Park JH
Pathol Res Pract; 2013 Nov; 209(11):700-4. PubMed ID: 24054033
[TBL] [Abstract][Full Text] [Related]
38. The brain acid-soluble protein 1 (BASP1) interferes with the oncogenic capacity of MYC and its binding to calmodulin.
Hartl M; Puglisi K; Nist A; Raffeiner P; Bister K
Mol Oncol; 2020 Mar; 14(3):625-644. PubMed ID: 31944520
[TBL] [Abstract][Full Text] [Related]
39. Localization of nucleophosmin in nuclear matrix and changes in its expression during the differentiation of human neuroblastoma induced by retinoic acid.
Shi SL; Liang Y; Li QF; Liu QR; Jing GJ; Wang SY; Zhang XY; Wu FY
J Cell Biochem; 2010 Sep; 111(1):67-74. PubMed ID: 20506166
[TBL] [Abstract][Full Text] [Related]
40. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
Tago K; Chiocca S; Sherr CJ
Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
